课题基金 / 基金详情

Broadening the Efficacy of Cancer Immunotherapies

Broadening the Efficacy of Cancer Immunotherapies
扩大癌症免疫疗法的功效
批准号：
nhmrc : GNT1159655
负责人：
A/Pr Michele Teng
金额：
$48.34万
依托单位：
依托单位国家：
澳大利亚
项目类别：
Career Development Fellowships
财政年份：
2019
资助国家：
澳大利亚
项目状态：
已结题
起止时间：
2019-01-01 至 --
来源：
https://researchdata.edu.au/broadening-efficacy-cancer-immunotherapies/1349304
关键词：
BroadeningEfficacyCancerImmunotherapies

项目摘要

项目成果

A/Pr Michele Teng的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Over the past 5 years, antibodies targeting immunomodulatory receptors such as Ipilimumab, Nivolumab/Pembrolizumab have been revolutionary in causing long term tumor regression and disease free survival in advanced cancers. My vision is to increase the proportion of cancer patients that will respond to immunotherapy by exploring novel pathways and combinations and optimizing their scheduling and assessing their safety in mouse models to allow their rapid translation into the clinic.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Co-inhibition of adenosine generation and signalling: a new combination cancer therapy
  • 批准号：
    nhmrc : GNT1120887
  • 项目类别：
    Project Grants
  • 资助金额：
    $58.79万
  • 财政年份：
    2017
  • 负责人：
    A/Pr Michele Teng
  • 依托单位：
Co-inhibition of adenosine generation and signalling: a new combination cancer therapy
New target pathway for cancer therapy
  • 批准号：
    nhmrc : GNT1098960
  • 项目类别：
    Project Grants
  • 资助金额：
    $73.92万
  • 财政年份：
    2016
  • 负责人：
    A/Pr Michele Teng
  • 依托单位：
New target pathway for cancer therapy
海外基金